Harel Insurance Investments & Financial Services’s SOPHiA GENETICS SOPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,151
Closed -$4K 756
2022
Q2
$4K Buy
+1,151
New +$5.84K ﹤0.01% 691
2022
Q1
Sell
-1,520
Closed -$20K 804
2021
Q4
$20K Buy
+1,520
New +$22.4K ﹤0.01% 674

Other funds holding SOPH

Harel Insurance Investments & Financial Services's SOPH Position: Q3 2022 in Review

Harel Insurance Investments & Financial Services sold out of SOPHiA GENETICS (SOPH) in Q3 2022, closing a stake of 1,151 shares — an estimated $4K sold.

Harel Insurance Investments & Financial Services first reported a position in SOPH in Q4 2021 and held it in 2 quarters. The position peaked at $20K in Q4 2021. 34 funds tracked by Wall St. Rank hold SOPH as of Q3 2022.

  • Harel Insurance Investments & Financial Services reported no remaining SOPHiA GENETICS position as of Q3 2022 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 1,151 SOPHiA GENETICS shares in Q3 2022, an estimated $4K.
  • Harel Insurance Investments & Financial Services first reported a position in SOPHiA GENETICS in Q4 2021 and held it in 2 quarters.
  • Harel Insurance Investments & Financial Services's SOPHiA GENETICS position peaked at $20K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q3 2022.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2022, filed 31 Oct 2022.